ImmunityBio, Inc. revenue breakdown overview

ImmunityBio, Inc. revenue for the last year amounted to 611.00 k USD, the most of which — 622.00 k USD — came from its highest performing source at the moment, Immunotherapies, the year earlier bringing 240.00 k USD. The greatest contribution to the revenue figure was made by Europe — last year it brought ImmunityBio, Inc. 591.00 k USD, and the year before that — 198.00 k USD.